Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharma funding declines 94.52% in Nov 2024
As per Tracxn report, seed-stage and early-stage investments dominate as top deals raise $3.1 million
Gland Pharma secures US FDA approval for Latanoprost Ophthalmic Solution
Product targets treatment of high intraocular pressure in glaucoma and ocular hypertension patients
Granules India’s Gagillapur facility classified as “Official Action Indicated” following US FDA…
Company responds to observations and initiates improvements in collaboration with external experts
ACG covers every facet of the pharma process, all under one roof and seamlessly interconnected
ACG Inspection’s Life Sciences Cloud will be making its India debut at the CPhI India- PMec India 2024 show. Udit Singh, CEO, ACG…
Indoco strategic collaboration aims to strengthen Indoco Remedies’ presence in the UK pharma market
Remedies partners with Clarity Pharma to launch 20 products in the UK
Race for approval of first oral GLP-1R drug in obesity intensifies with four in phase III trials:…
Oral GLP-1 receptor drugs emerge as the next frontier in obesity treatment, with key players racing for first approval amidst…
We, at OmniActive, invest over 10 per cent of the total outlay into R&D
Sanjaya Mariwala, Executive Chairman and MD, OmniActive Health Technologies shares insights into the company’s significant…
30 years and counting …
The pharma industry has breached many barriers, but we have miles to go before we can rest on our laurels
Maharashtra Government appoints Rajesh Narvekar as FDA Commissioner
Narvekar assumes the role following the retirement of Abhimanyu Kale, bringing decades of administrative experience
Biocon Biologics receives FDA approval for biosimilar YESINTEK
The biosimilar Ustekinumab-kfce is set for commercialisation in the US by February 2025 under a licensing agreement with Janssen